Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki Wang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
Cells|April 12, 2022
Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced ModelPei-Lun Lai, Chi-Hou Ng, Chia-Hsin Wu, et al.
Journal of Biomedical Science|April 16, 2024
Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark miceVicki Wang, Kuan-Yin Tseng, Tung-Tai Kuo, et al.
Cell Death & Disease|February 15, 2023
Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhageKuan-Yin Tseng, Vassilis Stratoulias, Wei-Fen Hu, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's DiseaseVicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
Cells|April 12, 2022
Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced ModelPei-Lun Lai, Chi-Hou Ng, Chia-Hsin Wu, et al.
Journal of Biomedical Science|April 16, 2024
Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark miceVicki Wang, Kuan-Yin Tseng, Tung-Tai Kuo, et al.
Cell Death & Disease|February 15, 2023
Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhageKuan-Yin Tseng, Vassilis Stratoulias, Wei-Fen Hu, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's DiseaseVicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, et al.
Pageof 2